Michael D. Mulholland
2013 - CytoDyn
In 2013, Michael D. Mulholland earned a total compensation of $412.3K as Chief Financial Officer at CytoDyn.
Compensation breakdown
| Bonus | $87,500 |
|---|---|
| Option Awards | $241,306 |
| Salary | $82,228 |
| Other | $1,313 |
| Total | $412,347 |
Mulholland received $241.3K in option awards, accounting for 59% of the total pay in 2013.
Mulholland also received $87.5K in bonus, $82.2K in salary and $1.3K in other compensation.
Rankings
In 2013, Michael D. Mulholland's compensation ranked 9,949th out of 12,286 executives tracked by ExecPay. In other words, Mulholland earned more than 19.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,949 out of 12,286 | 19th |
Division Manufacturing | 3,695 out of 4,612 | 20th |
Major group Chemicals And Allied Products | 1,171 out of 1,462 | 20th |
Industry group Drugs | 914 out of 1,156 | 21st |
Industry Pharmaceutical Preparations | 712 out of 890 | 20th |
Source: SEC filing on January 22, 2015.
Mulholland's colleagues
We found one more compensation record of an executive who worked with Michael D. Mulholland at CytoDyn in 2013.
2013
Nader Pourhassan
CytoDyn